Printer Friendly
The Free Library
22,738,802 articles and books

ESTRO Announces Press Programme for 2008 Annual Congress.



BRUSSELS, Belgium, July 11 /PRNewswire/ --

- The European Society for Therapeutic Radiology and Oncology to Hold Press Conference With 4 Major Topics on Monday 15 September 2008.

More than 4,500 cancer and radiotherapy radiotherapy /ra·dio·ther·a·py/ (-ther´ah-pe) treatment of disease by means of ionizing radiation; tissue may be exposed to a beam of radiation, or a radioactive element may be contained in devices (e.g.  specialists will gather in GE[micro]teborg this September for the 27th annual congress of ESTRO ESTRO European Society for Therapeutic Radiology and Oncology . ESTRO 27 is to be held between the 14th and 18th September 2008 at the GE[micro]teborg Convention Centre in GE[micro]teborg, Sweden.

The congress will include teaching sessions, lectures, presentations of major breakthroughs, posters and discussions dealing with the different areas covered by Radiotherapy such as physics, radiobiology, clinical radiotherapy and brachytherapy brachytherapy /brachy·ther·a·py/ (-ther´ah-pe) treatment with ionizing radiation whose source is applied to the surface of the body or within the body a short distance from the area being treated. . More than 1,500 abstracts have been submitted, which is the highest number ESTRO has ever received.

The congress will also present the largest industrial exhibition of radiotherapy in Europe with brand new materials exposed on 10,000 m2.

PRESS PROGRAMME SCHEDULE

Monday 15 September, 1.15 pm to 2.30 pm

Opening press conference

ESTRO's President, Vincent Gregoire will present the main sessions of the congress and will describe the latest moves and major happenings occurring in the different fields of Radiotherapy.

New clinical results in radio-oncology in 2008

Data on new phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA  trial on various sites will be presented for the first time.

Swedish proton therapy Proton therapy is a type of particle therapy which utilizes a beam of protons to irradiate a tumor site. Introduction
Proton therapy is of interest because of its ability to accurately target and kill tumors, both near the surface and deep seated within the body, while
 project

Sweden will launch a new process that is unique in Europe for treating cancer. The concept of 'distributed competence' involves 8 Swedish university hospitals that perform treatment plans close to the patients' home, who are then treated in a single place, at the proton centre of the Skandion clinic.

Radiotherapy Information Centre

ESTRO is launching a unique radiotherapy information tool in Europe. Dedicated to radiotherapy professionals, but also to patients and the media, it will provide very useful data that can be adapted for use by different public mediums.

Notes to Editors

The European Society for Therapeutic Radiology and Oncology (ESTRO) was founded in 1980 and today, with more than 5,000 members, the society promotes Radiolotherapy among all disciplines in cancer treatment and research.

ESTRO provides educational and continuing professional development CPD is the means by which members of professional associations maintain, improve and broaden their knowledge and skills and develop the personal qualities required in their professional lives.  programmes to oncologists and also disseminates research results, organises meetings and conferences for all professionals involved in delivering Radiotherapy - radio- therapists, biologists, physicists and oncology nurses - to improve patient care.

    Press Office:
    Cecile Hardon
    cecile.hardon@estro.be

    ESTRO
    Avenue E. Mounier, 83 - 1200
    Brussels
    Belgium
    Tel: +32-2-761-06-51

    http://www.estro.org



Press Office:, Cecile Hardon, cecile.hardon@estro.be; ESTRO, Avenue E. Mounier, 83 - 1200 , Brussels, Belgium,Tel: +32-2-761-06-51
COPYRIGHT 2008 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire Europe
Date:Jul 11, 2008
Words:416
Previous Article:Vive la St Pancras International - Europe's Destination Station.
Next Article:Harley-Davidson to Acquire MV Agusta Group Expanding Presence in Europe.
Topics:



Related Articles
Estro enters cyberspace.
Breast Cancer: Radiation Therapy Indispensable.
Stem Cells can Reduce the Side Effects of Radiation Therapy.
Radiation Therapy for Prostate Cancer: More Effective in Combination.
Lung Cancer: New Techniques Improve Radiation Therapy.
Pre-alert: 23rd Annual EAU Congress to be Held in Milan, Italy.
Nucletron Announces Advances in Image-Guided Adaptive Brachytherapy Technology for Gynecologic Cancers Through Partnership With AKH / MUW Vienna.
Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy.
Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters